.png)
Primary Cells Market By Origin (Skeletal and Muscle Cells, Gastrointestinal Cells, Hematopoietic Cells, Renal Cells, Liver Cells, Lung Cells, Skin Cells, Heart and Other Origin), Type (Animal Primary Cells and Human Primary Cells) and End User (Life Science Research Companies and Research Institutes) - Global Industry Analysis And Forecast To 2027
Published On : September 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC091299
SEGMENTS & REGIONS:
- By Origin: Skeletal and Muscle Cells, Gastrointestinal Cells, Hematopoietic Cells, Renal Cells, Liver Cells, Lung Cells, Skin Cells, Heart and Other Origin
- Type: Animal Primary Cells and Human Primary Cells
- and End User: Life Science Research Companies and Research Institutes
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook
Primary Cells are cells directly derived from living tissues and used for growth of vitro. Primary cells can be derived from various living organisms including humans. Human primary cells can be used for obtaining various data related to humans related to biological terms. Primary Cells are extracted directly from tissues of various living beings using mechanical or enzymatic methods. The use of Primary Cells is increasing due to factors like; rising number of cell related research works, fast growing biopharmaceutical & biotechnology sectors, rising research to tackle cancer, increase in the expenditure on healthcare sector, rising demand for monoclonal (single cell) antibodies, number of advantages of primary cells over cell lines, increasing use in the field of live science research, etc. Therefore, the Primary Cells Market is anticipated to expand and has tremendous scope during the forecast period. The global Primary Cells Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Primary Cells Market is based on segment, by Origin the market is segmented into Skeletal and Muscle Cells, Gastrointestinal Cells, Hematopoietic Cells, Renal Cells, Liver Cells, Lung Cells, Skin Cells, Heart and Other Origin, by Type the market is segmented into Animal Primary Cells and Human Primary Cells, and by End User the market is segmented into Life Science Research Companies and Research Institutes.
- Primary Cells Market, By Origin
- Skeletal and Muscle Cells
- Gastrointestinal Cells
- Hematopoietic Cells
- Renal Cells
- Liver Cells
- Lung Cells
- Skin Cells
- Heart
- Other Origin
- Primary Cells Market, By Type
- Animal Primary Cells
- Human Primary Cells
- Primary Cells Market, By End User
- Life Science Research Companies
- Research Institutes
Regional Insights
On a global front, the Primary Cells Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). American region is leading the Primary Cells Market owing to; increasing cases of cancer, rise in funding from government for R&D, technical development & well developed healthcare sector.
Primary Cells Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are American Type Culture Collection (ATCC), Lonza, Axol Biosciences, Thermo Fisher Scientific, ALLCells, STEMCELL Technologies, Merck KGaA, ZenBio Inc., Cell Biologics and Promocell. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- American Type Culture Collection (ATCC)
- Lonza
- Axol Biosciences
- Thermo Fisher Scientific
- ALLCells
- STEMCELL Technologies
- Merck KGaA
- ZenBio Inc.
- Cell Biologics
- Promocell
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Primary Cells Market, By Origin, Estimates and Forecast, 2017-2027 ($Million)
o Skeletal and Muscle Cells
o Gastrointestinal Cells
o Hematopoietic Cells
o Renal Cells
o Liver Cells
o Lung Cells
o Skin Cells
o Heart
o Other Origin
o Primary Cells Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Animal Primary Cells
o Human Primary Cells
o Primary Cells Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Life Science Research Companies
o Research Institutes
o Primary Cells Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Primary Cells Market, By Country
o U.S. Primary Cells Market
o Canada Primary Cells Market
o Mexico Primary Cells Market
o Europe
§ Europe Primary Cells Market, By Country
o Germany Primary Cells Market
o UK Primary Cells Market
o France Primary Cells Market
o Russia Primary Cells Market
o Italy Primary Cells Market
o Rest of Europe Primary Cells Market
o Asia-Pacific
§ Asia-Pacific Primary Cells Market, By Country
o China Primary Cells Market
o Japan Primary Cells Market
o South Korea Primary Cells Market
o India Primary Cells Market
o Southeast Asia Primary Cells Market
o Rest of Asia-Pacific Primary Cells Market
o South America
§ South America Primary Cells Market, By Country
o Brazil Primary Cells Market
o Argentina Primary Cells Market
o Columbia Primary Cells Market
o Rest of South America Primary Cells Market
o Middle East and Africa
§ Middle East and Africa Primary Cells Market, By Country
o Saudi Arabia Primary Cells Market
o UAE Primary Cells Market
o Egypt Primary Cells Market
o Nigeria Primary Cells Market
o South Africa Primary Cells Market
o Rest of MEA Cervical Pillows Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Primary Cells Market, By Origin
5.1. Introduction
5.2. Global Primary Cells Revenue and Market Share by Origin (2017-2027)
5.2.1. Global Primary Cells Revenue and Revenue Share by Origin (2017-2027)
5.3. Skeletal and Muscle Cells
5.3.1. Global Skeletal and Muscle Cells Revenue and Growth Rate (2017-2027)
5.4. Gastrointestinal Cells
5.4.1. Global Gastrointestinal Cells Revenue and Growth Rate (2017-2027)
5.5. Hematopoietic Cells
5.5.1. Global Hematopoietic Cells Revenue and Growth Rate (2017-2027)
5.6. Renal Cells
5.6.1. Global Renal Cells Revenue and Growth Rate (2017-2027)
5.7. Liver Cells
5.7.1. Global Liver Cells Revenue and Growth Rate (2017-2027)
5.8. Lung Cells
5.8.1. Global Lung Cells Revenue and Growth Rate (2017-2027)
5.9. Skin Cells
5.9.1. Global Skin Cells Revenue and Growth Rate (2017-2027)
5.10. Heart
5.10.1. Global Heart Revenue and Growth Rate (2017-2027)
5.11. Other Origin
5.11.1. Global Other Origin Revenue and Growth Rate (2017-2027)
6. Primary Cells Market, By Type
6.1. Introduction
6.2. Global Primary Cells Revenue and Market Share by Type (2017-2027)
6.2.1. Global Primary Cells Revenue and Revenue Share by Type (2017-2027)
6.3. Animal Primary Cells
6.3.1. Global Animal Primary Cells Revenue and Growth Rate (2017-2027)
6.4. Human Primary Cells
6.4.1. Global Human Primary Cells Revenue and Growth Rate (2017-2027)
7. Primary Cells Market, By End User
7.1. Introduction
7.2. Global Primary Cells Revenue and Market Share by End User (2017-2027)
7.2.1. Global Primary Cells Revenue and Revenue Share by End User (2017-2027)
7.3. Life Science Research Companies
7.3.1. Global Life Science Research Companies Revenue and Growth Rate (2017-2027)
7.4. Research Institutes
7.4.1. Global Research Institutes Revenue and Growth Rate (2017-2027)
8. Primary Cells Market, By Region
8.1. Introduction
8.2. Global Primary Cells Revenue and Market Share by Regions
8.2.1. Global Primary Cells Revenue by Regions (2017-2027)
8.3. North America Primary Cells by Countries
8.3.1. North America Primary Cells Revenue and Growth Rate (2017-2027)
8.3.2. North America Primary Cells Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Primary Cells by Countries
8.4.1. Europe Primary Cells Revenue and Growth Rate (2017-2027)
8.4.2. Europe Primary Cells Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Primary Cells by Countries
8.5.1. Asia-Pacific Primary Cells Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Primary Cells Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Primary Cells by Countries
8.6.1. South America Primary Cells Revenue and Growth Rate (2017-2027)
8.6.2. South America Primary Cells Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Primary Cells by Countries
8.7.1. Middle East and Africa Primary Cells Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Primary Cells Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. American Type Culture Collection (ATCC)
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Lonza
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Axol Biosciences
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Thermo Fisher Scientific
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. ALLCells
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. STEMCELL Technologies
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Merck KGaA
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. ZenBio Inc.
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Cell Biologics
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Promocell
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Primary Cells Market Competition, by Manufacturer
10.1. Global Primary Cells Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Primary Cells Price By Region (2017-2017)
10.3. Top 5 Primary Cells Manufacturer Market Share
10.4. Market Competition Trend
11. Primary Cells Market Forecast (2017-2027)
11.1. Global Primary Cells Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Primary Cells Market Forecast by Regions (2017-2027)
11.2.1. North America Primary Cells Market Forecast (2017-2027)
11.2.1.1. United States Primary Cells Market Forecast (2017-2027)
11.2.1.2. Canada Primary Cells Market Forecast (2017-2027)
11.2.1.3. Mexico Primary Cells Market Forecast (2017-2027)
11.2.2. Europe Primary Cells Market Forecast (2017-2027)
11.2.2.1. Germany Primary Cells Market Forecast (2017-2027)
11.2.2.2. France Primary Cells Market Forecast (2017-2027)
11.2.2.3. UK Primary Cells Market Forecast (2017-2027)
11.2.2.4. Russia Primary Cells Market Forecast (2017-2027)
11.2.2.5. Italy Primary Cells Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Primary Cells Market Forecast (2017-2027)
11.2.3. Asia-Pacific Primary Cells Market Forecast (2017-2027)
11.2.3.1. China Primary Cells Market Forecast (2017-2027)
11.2.3.2. Japan Primary Cells Market Forecast (2017-2027)
11.2.3.3. Korea Primary Cells Market Forecast (2017-2027)
11.2.3.4. India Primary Cells Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Primary Cells Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Primary Cells Market Forecast (2017-2027)
11.2.4. South America Primary Cells Market Forecast (2017-2027)
11.2.4.1. Brazil Primary Cells Market Forecast (2017-2027)
11.2.4.2. Argentina Primary Cells Market Forecast (2017-2027)
11.2.4.3. Columbia Primary Cells Market Forecast (2017-2027)
11.2.4.4. Rest of South America Primary Cells Market Forecast (2017-2027)
11.2.5. Middle East and Africa Primary Cells Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Primary Cells Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Primary Cells Market Forecast (2017-2027)
11.2.5.3. Egypt Primary Cells Market Forecast (2017-2027)
11.2.5.4. Nigeria Primary Cells Market Forecast (2017-2027)
11.2.5.5. South Africa Primary Cells Market Forecast (2017-2027)
11.2.5.6. Turkey Primary Cells Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Primary Cells Market Forecast (2017-2027)
11.3. Primary Cells Market Forecast by Origin (2017-2027)
11.3.1. Primary Cells Forecast by Origin (2017-2027)
11.3.2. Primary Cells Market Share Forecast by Origin (2017-2027)
11.4. Primary Cells Market Forecast by Type (2017-2027)
11.4.1. Primary Cells Forecast by Type (2017-2027)
11.4.2. Primary Cells Market Share Forecast by Type (2017-2027)
11.5. Primary Cells Market Forecast by End User (2017-2027)
11.5.1. Primary Cells Forecast by End User (2017-2027)
11.5.2. Primary Cells Market Share Forecast by End User (2017-2027)
List of Tables
12. List of Tables and Figures
Figure United States Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Primary Cells Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Primary Cells Revenue and Revenue Share by Origin (2017-2018)
Figure Global Skeletal and Muscle Cells Revenue and Growth Rate (2017-2018)
Figure Global Gastrointestinal Cells Revenue and Growth Rate (2017-2018)
Figure Global Hematopoietic Cells Revenue and Growth Rate (2017-2018)
Figure Global Renal Cells Revenue and Growth Rate (2017-2018)
Figure Global Liver Cells Revenue and Growth Rate (2017-2018)
Figure Global Lung Cells Revenue and Growth Rate (2017-2018)
Figure Global Skin Cells Revenue and Growth Rate (2017-2018)
Figure Global Heart Revenue and Growth Rate (2017-2018)
Figure Global Other Origin Revenue and Growth Rate (2017-2018)
Table Global Primary Cells Revenue and Revenue Share by Type (2017-2018)
Figure Global Animal Primary Cells Revenue and Growth Rate (2017-2018)
Figure Global Human Primary Cells Revenue and Growth Rate (2017-2018)
Table Global Primary Cells Revenue and Revenue Share by End User (2017-2018)
Figure Global Life Science Research Companies Revenue and Growth Rate (2017-2018)
Figure Global Research Institutes Revenue and Growth Rate (2017-2018)
Table Global Primary Cells Revenue by Regions (2017-2018)
Figure North America Primary Cells Growth Rate (2017-2018)
Figure North America Primary Cells Revenue and Growth Rate (2017-2018)
Figure North America Primary Cells by Countries (2017-2018)
Figure North America Primary Cells Revenue (Million USD) by Countries (2017-2018)
Figure United States Primary Cells Growth Rate (2017-2018)
Figure United States Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Primary Cells Growth Rate (2017-2018)
Figure Canada Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Primary Cells Growth Rate (2017-2018)
Figure Mexico Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Primary Cells Growth Rate (2017-2018)
Figure Europe Primary Cells Revenue and Growth Rate (2017-2018)
Figure Europe Primary Cells by Countries (2017-2018)
Figure Europe Primary Cells Revenue (Million USD) by Countries (2017-2018)
Figure Germany Primary Cells Growth Rate (2017-2018)
Figure Germany Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Primary Cells Growth Rate (2017-2018)
Figure France Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Primary Cells Growth Rate (2017-2018)
Figure UK Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Primary Cells Growth Rate (2017-2018)
Figure Russia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Primary Cells Growth Rate (2017-2018)
Figure Italy Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Primary Cells Growth Rate (2017-2018)
Figure Rest of Europe Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Primary Cells Growth Rate (2017-2018)
Figure Asia-Pacific Primary Cells Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Primary Cells by Countries (2017-2018)
Figure Asia-Pacific Primary Cells Revenue (Million USD) by Countries (2017-2018)
Figure China Primary Cells Growth Rate (2017-2018)
Figure China Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Primary Cells Growth Rate (2017-2018)
Figure Japan Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Primary Cells Growth Rate (2017-2018)
Figure Korea Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Primary Cells Growth Rate (2017-2018)
Figure India Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Primary Cells Growth Rate (2017-2018)
Figure Southeast Asia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Primary Cells Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Primary Cells Growth Rate (2017-2018)
Figure South America Primary Cells Revenue and Growth Rate (2017-2018)
Figure South America Primary Cells by Countries (2017-2018)
Figure South America Primary Cells Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Primary Cells Growth Rate (2017-2018)
Figure Brazil Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Primary Cells Growth Rate (2017-2018)
Figure Argentina Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Primary Cells Growth Rate (2017-2018)
Figure Columbia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Primary Cells Growth Rate (2017-2018)
Figure Rest of South America Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Primary Cells Growth Rate (2017-2018)
Figure Middle East and Africa Primary Cells Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Primary Cells by Countries (2017-2018)
Figure Middle East and Africa Primary Cells Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Primary Cells Growth Rate (2017-2018)
Figure Saudi Arabia Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Primary Cells Growth Rate (2017-2018)
Figure United Arab Emirates Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Primary Cells Growth Rate (2017-2018)
Figure Egypt Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Primary Cells Growth Rate (2017-2018)
Figure Nigeria Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Primary Cells Growth Rate (2017-2018)
Figure South Africa Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Primary Cells Growth Rate (2017-2018)
Figure Turkey Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Primary Cells Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Primary Cells Revenue (Millions USD) and Growth Rate (2017-2018)
Table American Type Culture Collection (ATCC) Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lonza Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Axol Biosciences Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ALLCells Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table STEMCELL Technologies Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck KGaA Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ZenBio Inc. Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cell Biologics Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Promocell Primary Cells Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Primary Cells Market Share by Manufacturer
Figure Global Primary Cells Revenue and Market Share by Manufacturer
Table Global Primary Cells Price by Region (2017-2017)
Figure Top 5 Primary Cells Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Primary Cells Revenue (Millions USD) and Growth Rate (2018-2025)
Table Primary Cells Market Forecast by Regions (2018-2025)
Figure North America Primary Cells Market Forecast (2018-2025)
Figure United States Primary Cells Market Forecast (2018-2025)
Figure Canada Primary Cells Market Forecast (2018-2025)
Figure Mexico Primary Cells Market Forecast (2018-2025)
Figure Europe Primary Cells Market Forecast (2018-2025)
Figure Germany Primary Cells Market Forecast (2018-2025)
Figure France Primary Cells Market Forecast (2018-2025)
Figure UK Primary Cells Market Forecast (2018-2025)
Figure Russia Primary Cells Market Forecast (2018-2025)
Figure Italy Primary Cells Market Forecast (2018-2025)
Figure Rest of Europe Primary Cells Market Forecast (2018-2025)
Figure Asia-Pacific Primary Cells Market Forecast (2018-2025)
Figure China Primary Cells Market Forecast (2018-2025)
Figure Japan Primary Cells Market Forecast (2018-2025)
Figure Korea Primary Cells Market Forecast (2018-2025)
Figure India Primary Cells Market Forecast (2018-2025)
Figure Southeast Asia Primary Cells Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Primary Cells Market Forecast (2018-2025)
Figure South America Primary Cells Market Forecast (2018-2025)
Figure Brazil Primary Cells Market Forecast (2018-2025)
Figure Argentina Primary Cells Market Forecast (2018-2025)
Figure Columbia Primary Cells Market Forecast (2018-2025)
Figure Rest of South America Primary Cells Market Forecast (2018-2025)
Figure Middle East and Africa Primary Cells Market Forecast (2018-2025)
Figure Saudi Arabia Primary Cells Market Forecast (2018-2025)
Figure United Arab Emirates Primary Cells Market Forecast (2018-2025)
Figure Egypt Primary Cells Market Forecast (2018-2025)
Figure Nigeria Primary Cells Market Forecast (2018-2025)
Figure South Africa Primary Cells Market Forecast (2018-2025)
Figure Turkey Primary Cells Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Primary Cells Market Forecast (2018-2025)
Figure Global Primary Cells Forecast by Origin (2018-2025)
Figure Global Primary Cells Market Share Forecast by Origin (2018-2025)
Figure Global Primary Cells Forecast by Origin (2018-2025)
Figure Global Primary Cells Forecast by Type (2018-2025)
Figure Global Primary Cells Market Share Forecast by Type (2018-2025)
Figure Global Primary Cells Forecast by Type (2018-2025)
Figure Global Primary Cells Forecast by End User (2018-2025)
Figure Global Primary Cells Market Share Forecast by End User (2018-2025)
Figure Global Primary Cells Forecast by End User (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|